Synergistic inhibition of CHK1 and MUS81 to combat replication stress resistance in high-risk neuroblastoma.
- DOI
- 10.1038/s41598-025-29898-z
- Published
- 2025 Nov 27
- Container
- Scientific reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-025-29898-z,
title = {Synergistic inhibition of CHK1 and MUS81 to combat replication stress resistance in high-risk neuroblastoma.},
author = {Hilgert E and Van Neste C and Bekaert SL and Martens F and Vanhauwaert S and Sanders E and Verstraelen P and Risseeuw M and Westerhout EM and Grannetia MA and Van Calenbergh S and Van Roy N and De Vos WH and Wolthuis RWF and Speleman F and Depestel L and Durinck K},
year = {2025},
journal = {Scientific reports},
doi = {10.1038/s41598-025-29898-z},
url = {https://doi.org/10.1038/s41598-025-29898-z}
}RIS
TY - JOUR TI - Synergistic inhibition of CHK1 and MUS81 to combat replication stress resistance in high-risk neuroblastoma. AU - Hilgert E AU - Van Neste C AU - Bekaert SL AU - Martens F AU - Vanhauwaert S AU - Sanders E AU - Verstraelen P AU - Risseeuw M AU - Westerhout EM AU - Grannetia MA AU - Van Calenbergh S AU - Van Roy N AU - De Vos WH AU - Wolthuis RWF AU - Speleman F AU - Depestel L AU - Durinck K PY - 2025 JO - Scientific reports DO - 10.1038/s41598-025-29898-z UR - https://doi.org/10.1038/s41598-025-29898-z ER -
APA
E, H., C, V. N., SL, B., F, M., S, V., E, S., P, V., M, R., EM, W., MA, G., S, V. C., N, V. R., WH, D. V., RWF, W., F, S., L, D., & K, D. (2025). Synergistic inhibition of CHK1 and MUS81 to combat replication stress resistance in high-risk neuroblastoma.. Scientific reports. https://doi.org/10.1038/s41598-025-29898-z
Source records
- pubmed · retrieved 2026-09-26T21:25:09.011Z